Ranolazine
Synonym(s):(±)-N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-ylacetamide;(±)-4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2′,6′-xylidide
- CAS NO.:95635-55-5
- Empirical Formula: C24H33N3O4
- Molecular Weight: 427.54
- MDL number: MFCD00864690
- EINECS: 620-450-7
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-05-21 21:51:03
![Ranolazine Structural](https://img.chemicalbook.in/CAS/GIF/95635-55-5.gif)
What is Ranolazine?
Absorption
The time to reach peak serum concentration is quite variable but has been observed to be in the range of 2-6 hours, with steady-state within 3 days. The FDA indicates a Tmax of 3-5 hours. The average steady-state Cmax is about 2600 ng/mL. Absorption of ranolazine is not significantly affected by food consumption. The bioavailability of ranolazine taken in the tablet form compared to that from a solution of ranolazine is about 76%.
Toxicity
The reported LD50 of oral ranolazine in the rat is 980 mg/kg. High oral doses of ranolazine have led to dizziness, nausea, and vomiting. These effects have been shown to be dose related. High intravenous doses can cause diplopia, confusion, paresthesia, in addition to syncope. In the case of an overdose, provide supportive therapy accompanied by continuous ECG monitoring for QT interval prolongation.
Description
Ranolazine is an orally available, extended release drug for the treatment of chronic angina in patients who have failed to respond to prior angina therapy. Chronic stable angina (CSA) is a common symptom of coronary artery disease wherein plaques in the coronary vasculature restrict blood flow to the heart, which in turn leads to insufficient oxygenation of the heart, typically during physical exertion or emotional stress. A vast majority of the existing anti-anginal and anti-ischemic therapies aim to correct the imbalance between myocardial oxygen demand and supply through mechanisms that produce reductions in heart rate or blood pressure.
The Uses of Ranolazine
Ranolazine is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.
Indications
Ranolazine is indicated for the treatment of chronic angina. It can be used alone or in conjunction with nitrates, beta-blockers, angiotensin receptor blockers, anti-platelet drugs, calcium channel blockers, lipid-lowering drugs, and ACE inhibitors.
Ranolazine has also been used off-label for the treatment of certain arrhythmias, including ventricular tachycardia, however, this use is not strongly supported by scientific evidence. Ranolazine has also been studied for the treatment of acute coronary syndrome, microvascular coronary dysfunction, arrhythmia, and glycemic control, which are not yet approved indications.
Background
Chronic angina is a common cardiovascular condition affecting millions worldwide and causes significant disability while interfering with daily activities. Ranolazine is a well-tolerated piperazine derivative used for the management of this condition, offering relief from uncomfortable and debilitating symptoms. With a mechanism of action different from drugs used to treat the same condition, ranolazine is a promising anti-anginal therapy. It was originally approved by the FDA in 2006.
What are the applications of Application
Ranolazine is an anti-ischemic agent which inhibits late sodium currents
Pharmacokinetics
Ranolazine exerts both antianginal and ischemic effects independent from lowering heart rate or blood pressure. It blocks IKr, the rapid portion of the delayed rectifier potassium current, and prolongs the QTc interval in a dose-dependent fashion. The Ikr is important for cardiac repolarization. Ranolazine exerts its therapeutic effects without negative chronotropic, dromotropic, or inotropic actions neither at rest, nor during exercise.
Metabolism
Ranolazine is rapidly heavily metabolized in the liver an gastrointestinal tract through the activity of the CYP3A4 enzyme with minor contributions from CYP2D6. More than 40 ranolazine metabolites have been found in plasma and more than 100 metabolites have been identified in the urine.
Ranolazine and some of its metabolites are known to weakly inhibit CYP3A4. However, the activity of the metabolites of ranolazine has not been fully elucidated.
Properties of Ranolazine
Melting point: | 119-1200C |
Boiling point: | 624.1±55.0 °C(Predicted) |
Density | 1.174±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Room Temperature |
solubility | DMSO (Slightly), Methanol (Slightly) |
form | Solid |
color | White |
Safety information for Ranolazine
Computed Descriptors for Ranolazine
Abamectin manufacturer
Cadila Pharmaceuticals Ltd
Dr. Reddy's Laboratories Ltd
KARPSCHEM LABORATORIES PVT. LTD.
New Products
3-N-BOC-(S)-AMINO BUTYRONITRILE 4-Piperidinopiperidine N-Benzyl-3-hydroxypiperidine 2-Methyl-4-nitrobenzoic acid 2-(4-bromophenyl)-2-methylpropanoic acid 4-Acetyl-2-methylbenzoicacid Acetyl-meldrum's acid Ethyl-4-Pyrazole carboxylate 2,6-Pyridinedimethanol 5,7-Dichloro-3H-Imidazo[4,5-B]Pyridine 5-Bromo-2-Methoxy-4-Methyl-3-Nitropyridine 2-Fluoro-5-Iodopyridine 2-Fluoro-5-Methylpyridine 2-Chloro-3-Bromo-5-Amiopyridine METHYL-4-(BUTYRYLAMINO)3-METHYL-5-NITROBENZOATE TRANS-CYCLOBUTANE-1,2- DICARBOXYLIC ACID 5-Nitro indazole R-(-)-5-(2-AMINO-PROPYL)-2-METHOXY-BENZENESULFONAMIDE 1,3-cyclohexanedione 4-Aminophenaethylalchol (S)-(+)-4-BENZYL-2-OXAZOLIDINONE 3-NITRO-5-ACETYL IMINODIBENZYL 4-FLUORO PHENYL MAGNESIUM BROMIDE 1.0 M IN THF 1-HYDROXY-4-METHYL6-(2,4,4-TRI METHYL PHENYL)-2-PYRIDONE MONO ETHANOL AMINE(PIROCTONE OLAMINE)Related products of tetrahydrofuran
![](https://img.chemicalbook.in/CAS/GIF/107-91-5.gif)
![](https://img.chemicalbook.in/CAS/GIF/121-79-9.gif)
![](https://img.chemicalbook.in/CAS/GIF/95635-56-6.gif)
![](https://img.chemicalbook.in/CAS/GIF/62-55-5.gif)
![](https://img.chemicalbook.in/CAS/GIF/105-66-8.gif)
![](https://img.chemicalbook.in/CAS/GIF/1914-99-4.gif)
![](https://img.chemicalbook.in/CAS/GIF/60-35-5.gif)
![](https://img.chemicalbook.in/CAS/GIF/127-19-5.gif)
You may like
-
Ranolazine 98%View Details
95635-55-5 -
Ranolazine 95635-55-5 98%View Details
95635-55-5 -
95635-55-5 98%View Details
95635-55-5 -
Ranolazine 98%View Details
95635-55-5 -
Ranolazine 98%View Details
-
95635-55-5 Ranolazine 98%View Details
95635-55-5 -
Ranolazine 99%View Details
95635-55-5 -
95635-55-5 99%View Details
95635-55-5